Table 1 Correlation between PANDAR expression and clinicopathological features of UCB patients
Parameters Total | Group | Total | PANDAR expression | p value | |
|---|---|---|---|---|---|
High | Low | ||||
Gender | Male | 40(73%) | 27(49%) | 13(24%) | 1.000 |
Female | 15(27%) | 10(18%) | 5(9%) | ||
Age (years) | < 60 | 20(36%) | 14(25%) | 6(11%) | 0.745 |
≥ 60 | 35(64%) | 23(42%) | 12(22%) | ||
Tumor size (cm) | < 3 cm | 21(38%) | 11(20%) | 10(18%) | 0.064 |
≥ 3 cm | 34(62%) | 26(47%) | 8(15%) | ||
Multiplicity | Single | 32(58%) | 21(38%) | 11(20%) | 0.759 |
Multiple | 23(42%) | 16(29%) | 7(13%) | ||
Histological grade | L | 23(42%) | 11(20%) | 12(22%) | 0.009 * |
H | 32(58%) | 26(47%) | 6(11%) | ||
Tumor stage T | T1,T2 | 38(69%) | 22(40%) | 16(29%) | 0.027 * |
T3,T4 | 17(31%) | 15(27%) | 2(4%) | ||
Lymph nodes metastasis | NO | 53(96%) | 36(65%) | 17(31%) | 1.000 |
YES | 2(4%) | 1(2%) | 1(2%) | ||